| Report ID | 276799 |
| Drug Identification Number | 02297256 |
| Brand name | MIRAPEX |
| Common or Proper name | Mirapex 0.125mg |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE |
| Strength(s) | 0.125MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3X10 |
| Anatomical Therapeutical Chemical (ATC) code | N04BC |
| Anatomical Therapeutical Chemical (ATC) description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-03-23 |
| Actual start date | |
| Estimated end date | 2026-06-02 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-01-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-28 | French | Compare |
| v1 | 2026-01-28 | English | Compare |
Showing 1 to 2 of 2